We are live on
!
Find out more
OCM
Osterweis Capital Management Portfolio holdings
AUM
$2.12B
1-Year Est. Return
32.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.38%
1 Year Est. Return
+32.36%
3 Year Est. Return
+93.72%
5 Year Est. Return
+113.14%
10 Year Est. Return
+557.09%
AUM
$1.45B
AUM Growth
+$74.6M
(+5.4%)
Cap. Flow
-$319M
Cap. Flow
% of AUM
-22.04%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
126
New
17
Increased
24
Reduced
47
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$23.2M |
| 2 |
Progressive
PGR
|
+$22.7M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$15M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$10.2M |
| 5 |
Johnson & Johnson
JNJ
|
+$9.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$25.6M |
| 2 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$23.7M |
| 3 |
Blue Bird Corp
BLBD
|
+$23.2M |
| 4 |
FedEx
FDX
|
+$19.6M |
| 5 |
Brookfield
BN
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.98% |
| 2 | Technology | 18.63% |
| 3 | Healthcare | 14.93% |
| 4 | Financials | 13.13% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
76
DELISTED
Abiomed Inc
ABMD
| $1.66M | 0.12% |
9,755
-2,215
| -19% | -$411K |
|
77
LendingTree
TREE
$373M
| $1.63M | 0.11% |
+5,380
| New | +$1.78M |
|
78
Etsy
ETSY
$6.73B
| $1.42M | 0.1% |
32,020
-49,565
| -61% | -$2.36M |
|
79
ExxonMobil
XOM
$682B
| $1.31M | 0.09% |
18,743
-475
| -2% | -$32.8K |
|
80
Merck
MRK
$355B
| $1.11M | 0.08% |
12,821
| – | – |
|
|
OPRA
81
Opera Ltd
OPRA
$1.64B
| $958K | 0.07% |
+103,520
| New | +$1.02M |
|
82
Union Pacific
UNP
$168B
| $919K | 0.06% |
5,083
| – | – |
|
83
Beyond Meat
BYND
$179M
| $796K | 0.06% |
+351
| New | +$977K |
|
84
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.79B
| – | – |
0
| – | – |
|
|
WBA
85
DELISTED
Walgreens Boots Alliance
WBA
| $558K | 0.04% |
9,463
+133
| +1% | +$7.67K |
|
86
Wells Fargo
WFC
$268B
| $550K | 0.04% |
10,214
-762
| -7% | -$39.9K |
|
87
Chevron
CVX
$419B
| $428K | 0.03% |
3,553
-751
| -17% | -$88.5K |
|
88
Bristol-Myers Squibb
BMY
$131B
| $399K | 0.03% |
6,209
-305
| -5% | -$17.5K |
|
|
89
FedEx
FDX
$71.7B
| $353K | 0.02% |
2,335
-126,973
| -98% | -$19.6M |
|
90
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.1B
| – | – |
0
| – | – |
|
91
McGrath RentCorp
MGRC
$2.71B
| $301K | 0.02% |
3,939
| – | – |
|
92
Walt Disney
DIS
$185B
| $273K | 0.02% |
1,887
+100
| +6% | +$14K |
|
93
Adobe
ADBE
$101B
| $271K | 0.02% |
822
+77
| +10% | +$22.7K |
|
94
W.R. Berkley
WRB
$26.3B
| $267K | 0.02% |
8,692
| – | – |
|
95
American Express
AXP
$214B
| $223K | 0.02% |
1,792
| – | – |
|
96
Home Depot
HD
$306B
| $213K | 0.01% |
976
-174
| -15% | -$39.4K |
|
97
Ecolab
ECL
$77.1B
| $203K | 0.01% |
1,050
-83
| -7% | -$15.8K |
|
98
Thermo Fisher Scientific
TMO
$237B
| $203K | 0.01% |
+625
| New | +$190K |
|
99
AtriCure
ATRC
$2.87B
| – | – |
-162,959
| Closed | -$4.06M |
|
100
CareDx
CDNA
$2.76B
| – | – |
-114,190
| Closed | -$2.58M |
|
Similar funds
SP
CWP
MSR
CP
PCM
MWA
GC
PSC
Osterweis Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Osterweis Capital Management held 126 positions worth $1.45B, up 5.4% from $1.37B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Osterweis Capital Management withdrew a net $319M in Q4 2019, closing 15 positions and reducing 47 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $25.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Osterweis Capital Management opened a new position in Advanced Micro Devices worth $28.9M.
- Osterweis Capital Management's largest Q4 2019 buy was Advanced Micro Devices: 629,080 shares worth $28.9M.
- Osterweis Capital Management added most to Charles Schwab in Q4 2019, an estimated $10.2M increase.
- Osterweis Capital Management's biggest Q4 2019 reduction was Blue Bird Corp, cutting an estimated $23.2M.
- Osterweis Capital Management fully exited Unilever NV New York Registry Shares in Q4 2019, selling an estimated $25.6M.
- Osterweis Capital Management's ten largest holdings make up 33% of its $1.45B portfolio in Q4 2019.
- Osterweis Capital Management opened 17 new positions and closed 15 in Q4 2019.
- Osterweis Capital Management's portfolio value rose 5.4% quarter-over-quarter to $1.45B.
Based on Osterweis Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.